Givaudan (SWX:GIVN) is back in focus after third quarter sales exceeded analyst expectations, with both Fragrance & Beauty and Taste & Wellbeing performing ahead of forecasts and management reaffirming its long term targets.
The stronger third quarter has arrived alongside a sharp swing in sentiment, with Givaudan’s share price jumping 9.4% in the last day and delivering a 20.6% 1 month share price return, while the 1 year total shareholder return of 16.1% points to momentum rebuilding after a flat 5 year record.
Scan for other fragrance and ingredients specialists showing similar momentum by reviewing our curated list of 621 high quality undiscovered gems, while Givaudan’s results are putting the sector back on investors’ radar.
After a 15 month high and a CHF 3,817 share price that now sits slightly above analyst targets yet still at an estimated 13% intrinsic discount, is the market rightly cautious on Givaudan or behind the curve?
Compared with the last close at CHF 3,817, the most followed narrative pegs Givaudan’s fair value at CHF 2,886. The current rebound has taken the shares well above that implied level while sentiment is still catching up.
The proliferation of advanced synthetic biology and digital design technologies is accelerating the commoditization of flavors and fragrances, threatening Givaudan's established business model and undermining its ability to command premium prices for what are increasingly seen as replicable solutions, negatively impacting future revenue and margin expansion.
See why 1 investors see Givaudan as 32% overvalued.
Result: Fair Value of CHF2,886 (OVERVALUED)
Still, that bearish view could be challenged if Givaudan achieves broader volume growth across key regions, or if it introduces higher margin products that resonate with customers.
Find out about the key risks to this Givaudan narrative.
The bearish fair value narrative pins Givaudan at CHF 2,886, yet the SWS DCF model points a different way. Based on future cash flows, Givaudan at CHF 3,817 is viewed as undervalued relative to an estimated CHF 4,373 per share. Which signal would you trust more when the two are this far apart?
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Givaudan for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 184 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Confused by the mix of caution and optimism around Givaudan right now? Act while the data is fresh in your mind and weigh both sides using the 2 key rewards and 1 important warning sign.
If Givaudan has sharpened your curiosity, do not stop here. Use fresh data and clear filters to uncover other opportunities that might suit your approach.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com